Tasmar Tablet, Film Coated
NDC Package 0187-0938-07

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Tasmar (tolcapone) tablets is a medication used with other medications (levodopa/carbidopa) to treat Parkinson's disease. This formulation utilizes a tablet, film coated delivery system. Marketed by Bausch Health Us Llc, this product is identified by NDC 0187-0938 and is authorized under FDA application NDA020697.

Identification & Billing

NDC Package Code
0187-0938-07
Package Description
21 TABLET, FILM COATED in 1 BOTTLE
Product Code
0187-0938
11-Digit Billing Format
00187093807
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Tasmar
Non-Proprietary Name
Tolcapone
Substance Name
Tolcapone
Dosage Form
Tablet, Film Coated - A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
TOLCAPONE 100 mg/1
Pharmacologic Class
Usage Information
This medication is used with other medications (levodopa/carbidopa) to treat Parkinson's disease. Tolcapone belongs to a class of drugs known as COMT inhibitors. Many people taking levodopa for Parkinson's have problems with the effects of the levodopa wearing off between scheduled doses, causing symptoms to return or worsen. Tolcapone blocks a certain natural substance (COMT enzyme) that breaks down levodopa in the body. This effect allows the levodopa to last longer in the system so that it doesn't wear off before the next dose.

Regulatory & Marketing

Labeler Name
Bausch Health Us Llc
Product Type
Human Prescription Drug
FDA Application #
NDA020697
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
07-27-2004
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (0187-0938). Click a package code to view its specific billing and regulatory data.

0187-0938-01
90 TABLET, FILM COATED in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0187-0938-07 identifies a specific commercial package of 21 tablet, film coated in 1 bottle of Tasmar, a human prescription drug labeled by Bausch Health Us Llc. This tablet, film coated is formulated for oral use and contains tolcapone as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Bausch Health Us Llc on July 27, 2004. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

This medication is used with other medications (levodopa/carbidopa) to treat Parkinson's disease. Tolcapone belongs to a class of drugs known as COMT inhibitors. Many people taking levodopa for Parkinson's have problems with the effects of the levodopa wearing off between scheduled doses, causing symptoms to return or worsen. Tolcapone blocks a certain natural substance (COMT enzyme) that breaks down levodopa in the body. This effect allows the levodopa to last longer in the system so that it doesn't wear off before the next dose.

How is this Bausch Health Us Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00187093807. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0187-0938-07
11-Digit CMS (5-4-2)
00187-0938-07

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.